Loading organizations...
§ Private Profile · New York City, NY, USA
Kindbody is a technology company.
Kindbody provides comprehensive fertility and family-building care through a network of modern, tech-enabled clinics and integrated virtual services. Their offerings include IVF, egg freezing, and support for LGBTQ+ family-building. The company integrates medical expertise with digital tools to provide a seamless patient experience, emphasizing accessible pricing and empathetic care navigation across its full-service model.
Kindbody was founded by Gina Bartasi, who recognized the complexities and challenges individuals face when navigating fertility and healthcare systems. Her vision was to create a more intuitive and empowering process for patients. Bartasi established Kindbody to address these pain points, building a model focused on transforming access and delivery of essential reproductive health services.
Patients utilizing Kindbody’s services include individuals and couples seeking personalized fertility treatments and wellness support. The company's core mission is to ensure that everyone has access to convenient and affordable fertility and family-building care. Kindbody aims to lead a new generation of health and fertility care, prioritizing compassionate care and patient needs above all else.
Kindbody has raised $248.0M across 7 funding rounds.
Kindbody has raised $248.0M in total across 7 funding rounds.
Kindbody is a leading fertility clinic network and family-building benefits provider that operates tech-enabled clinics offering comprehensive reproductive healthcare services. It builds proprietary technology like the HIPAA-compliant KindEMR electronic medical record system, which standardizes care, enables online scheduling, virtual/in-person appointments, and an intuitive patient portal covering fertility assessments, IVF, egg freezing, genetic testing, donor/surrogacy services, adoption, postpartum care, and menopause support.[1][2][5][6] Kindbody serves patients directly at 35+ signature clinics and IVF labs, 400+ partner clinics across 113 countries, and provides employer benefits to over 133 companies covering millions of lives, solving accessibility, affordability, and fragmentation issues in fertility care by integrating clinics, technology, and benefits for superior outcomes at lower costs.[1][2]
The company targets individuals and couples pursuing family-building regardless of sex, orientation, or marital status, as well as employers seeking comprehensive benefits. It addresses high costs, stigma, lack of transparency, and inefficient care through vertical integration, AI enhancements, and patient-centric design, evidenced by rapid growth: ranked No. 72 on the 2024 Deloitte Technology Fast 500 and No. 30 in 2023.[1][2]
Kindbody was founded in 2018 by Gina Bartasi, who aimed to transform fertility care by making it more intuitive, empowering, and less daunting amid a fragmented healthcare system.[2][6] Bartasi envisioned vertical integration—combining clinics, technology, and employer benefits—after recognizing gaps in patient access, concierge services, and end-to-end support like mobile blood tests and IVF hand-holding.[3][6] Early traction came from its physician-led model and tech investments, quickly establishing it as the only provider owning and operating clinics while serving employers.[1][2] Pivotal moments include launching KindEMR for full-spectrum care standardization and expanding to dozens of clinics, earning Deloitte Fast 500 recognitions by 2023-2024 for explosive revenue growth.[1][2]
Kindbody rides the fertility tech wave, blending healthcare with AI, automation, and consumer-friendly design amid rising demand for family-building amid delayed parenthood, infertility rates, and employer benefits expansion.[1][3][5] Timing aligns with post-2018 shifts: Modern Fertility's at-home testing and apps like Natural Cycles popularized transparent data ownership, while Kindbody vertically integrates to offer end-to-end solutions beyond niche tools.[3] Market forces favoring it include employer mandates for fertility coverage, AI advancements in repro medicine (e.g., embryo selection), and verticalization trends for better outcomes/costs; it influences the ecosystem by setting standards for clinic-owned tech-benefits hybrids, partnering on R&D, and accelerating accessible precision fertility care globally.[1][2][4]
Kindbody's momentum positions it to dominate as fertility tech matures, with AI-driven personalization, cryo-automation, and global expansion likely driving further growth beyond Deloitte rankings.[1][4] Trends like AI precision medicine, employer benefits normalization, and holistic repro health (preconception to menopause) will shape its path, potentially through more acquisitions or tech licensing.[2][5] Its influence may evolve from disruptor to industry leader, redefining scalable family-building—echoing its mission to make fertility affordable and accessible for all, starting from Gina Bartasi's vision of empowered care.[6]
Kindbody has raised $248.0M across 7 funding rounds. Most recently, it raised $25.0M Other Equity in May 2023.
Kindbody has raised $248.0M in total across 7 funding rounds.
Kindbody's investors include Cheryl Pegus, Sam Chawla, Adverb Ventures, Greylock, GV, Erel Margalit, LAUNCH, Offline Ventures, Otherwise Fund, RRE Ventures, Spark Capital, Upfront Ventures.